Iron and iron Chelators: A review on potential effects on skin aging

Current Aging Science

Volumn 6, Issue 3, 2013, Pages 226-231

  Pouillot, Anne ^a   Polla, Ada ^b   Polla, Barbara S ^a  

^a Alchimie Forever   (Switzerland)

^b Alchimie Forever LLC   (United States)

Author keywords

Hemochromatosis; Iron; Iron chelators; Oxidative stress; Skin aging

Indexed keywords

2 FURILDIOXIME; COPPER; DEFERASIROX; DEFEROXAMINE; FERRITIN; HYDROXYL RADICAL; IRON; IRON CHELATING AGENT; MANGANESE; OXYGEN RADICAL; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUNSCREEN; UNCLASSIFIED DRUG;

BLOOD DONOR; BRAIN DISEASE; CHEMICAL REACTION; DUCHENNE MUSCULAR DYSTROPHY; ENERGY YIELD; ERYTHEMA; FENTON REACTION; GASTROINTESTINAL SYMPTOM; HABER WEISS REACTION; HEMOCHROMATOSIS; HUMAN; IRON CHELATION; IRON DEFICIENCY; IRON OVERLOAD; ISCHEMIA; LONGEVITY; NONHUMAN; NUDE MOUSE; OXIDATIVE STRESS; PHOTOAGING; PRIORITY JOURNAL; QUALITY OF LIFE; RECIPIENT; REPERFUSION INJURY; REVIEW; SKIN CARE; SKIN PROTECTION; SUNBURN; ULTRAVIOLET RADIATION; WELLBEING; WRINKLE;

EID: 84891822767     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/18746098112059990037     Document Type: Review

References (44)

1. Melov S, Ravenscroft J, Malik S, et al. Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000; 289(5484):1567-9.
2. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 2000; 899:136-47.
3. Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004; 6(3): 561-70.
4. Bissett DL, Chatterjee R, Hannon DP. Chronic ultraviolet radiation- induced increase in skin iron and the photoprotective effect of topically applied iron chelators. Photochem Photobiol 1991; 54(2): 215-23.
5. Bissett DL, Oelrich DM, Hannon DP. Evaluation of a topical iron chelator in animals and in human beings: short-term photoprotection by 2-furildioxime. J Am Acad Dermatol 1994; 31(4): 572-8.
6. Pourzand C, Watkin RD, Brown JE, Tyrrell RM. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci USA 1999; 96: 6751-6.
7. Pinkus R, Weiner L, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF- κB, and glutathione S-transferase gene expression. J Biol Chem 1996; 271(23): 13422-9.
8. Molin L, Wester PO. Cobalt, copper and zinc in normal and psoriatic epidermis. Acta Derm Venereol 1973; 53(6): 477-80.
9. David TJ, Wells FE, Sharpe TC, Gibbs AC, Devlin J. Serum levels of trace metals in children with atopic eczema. Br J Dermatol 1990; 122(4): 485-9.
10. Reelfs O, Tyrrell RM, Pourzand C. Ultraviolet A radiation-induced immediate iron release is a key modulator of the activation of NF- κB in human skin fibroblasts. J Invest Dermatol 2004; 122:1440-7.
11. Rogers J, Bush A, Cho HH, et al. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans 2008; 36:1282-7.
12. Cahill CM, Lahiri DK, Huang X, Rogers JT. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta 2009; 1790(7): 615-28.
13. Park KW, Baik HH, Jin BK. IL-13 induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo. J Immunol 2009; 183(7): 4666-74.
14. Hunter RL, Liu M, Choi DY, Cass WA, Bing G. Inflammation and age-related iron accumulation in F344 rats. Curr Aging Sci 2008; 1(2):112-21.
15. Templeton DM. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 2003; 1619(2):113-24.
16. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 2003; 102(7): 2670-7.
17. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20(4): 553-66.
18. Barton JC, Edwards CQ. Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Cambridge University Paris 2000.
19. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 2000; 343(8): 544-50.
20. Olivieiri NF. The β-thalassemias. N Engl J Med 1999; 341(2): 99-109.
21. Olivieiri NF. Progression of iron overload in sickle cell disease. Semin Hematol 2001; 38(Suppl 1): 57-62.
22. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341(26):1986-95.
23. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117(3): 285-97.
24. Masse PG, Dosy J, Cole DE, Evroski J, Allard J, D'Astous M. Is serum ferritin an additional cardiovascular risk factor for all postmenopausal women? Ann Nutr Metab 2004; 48(6): 381-9.
25. Klipstein-Grobusch K, Koster JF, Grobbee DE, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr 1999; 69(6):1231-6.
26. Rosenthal MD, Glew RH. Medical biochemistry. Human metabolism in health and disease. John Wiley & Sons 2009.
27. Polla BS. Therapy by taking away: the case of iron. Biochem Pharmacol 1999; 57(12):1345-9.
28. Kretchmar SA, Raymond KN. Further evaluation of the biphasic kinetics of iron removal from transferring by 3,4-LICAMS. Biol Met 1989; 2(2): 65-68.
29. Olivieiri NF, Koren G, Hermann C, et al. Comparison of oral iron chelator LY and desferrioxamine in iron-loaded patients. Lancet 1990; 336(8726): 1275-9.
30. Mira L, Fernandez MT, Santos M, Rocha R, Florênco MH, Jennings KR. Interactions of flavonoids with iron and copper iron: a mechanism for their antioxidant activity. Free Radic Res 2002; 36(11): 1199-1208.
31. Guo M, Perez C, Wei Y, et al. Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans 2007; 43: 4951-61.
32. Brewer GJ, Askari FK. Wilson's disease: clinical management and therapy. J Hepatol 2005; 42(Suppl1): 13-21.
33. Komatsu F, Kagawa Y, Kawabata T, Kaneko Y, Ishiguro K. Relationship of dietary habits and obesity to oxidative stress in Palauan people: compared with Japanese and Mongolian people. Curr Aging Sci 2009; 2(3): 214-22.
34. Komatsu F, Kagawa Y, Kawabata T, et al. A high accumulation of hair minerals in Mongolian people: 2nd Report; influence of manganese, iron, lead, cadmium and aluminium to oxidative stress, Parkinsonisms and arthritis. Curr Aging Sci 2011; 4: 42-56.
35. Emara Am, El Kelany RS, Moustafa KA. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats. Hum Exp Toxicol 2006; 25(7): 375-85.
36. Lim PS, Chan EC, Lu TC, et al. Lipophilic antioxidants and iron status in ESRD patients on hemodialysis. Nephron 2000; 86(4): 428-35.
37. 2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med 2006; 84(5): 349-64.
38. Farber NE, Vercellotti GM, Jacob HS, Pieper GM, Gross GJ. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res 1988; 63: 351-60.
39. Arkadopoulos N, Nastos C, Kalimeris K, et al. Iron chelation for amelioration of liver ischemia-reperfusion injury. Hemoglobin 2010; 34(3): 265-77.
40. Oshiro S, Morioka MS, Kikuchi M. Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011; 2011: 378278.
41. Mounsey RB, Teismann P. Chelators in the treatment of iron accumulation in Parkinson's disease. Int J Cell Biol 2012; 2012: 983245.
42. Bissett DL, McBride JF. Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen. J Am Acad Dermatol 1996; 35(4): 546-9.
43. Jurkiewicz BA, Buettner GR. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study. Photochem Photobiol 1994; 59(1): 1-4.
44. Brenneisen P, Wenk J, Klotz O, et al. Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J Biol Chem 1998; 273(9): 5279-87.